Transient pulmonary hypertension associated with esophageal sclerotherapy.
D000818:Animals; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005227:Fatty Acids / Q000009:adverse effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced*; D012597:Sclerosing Solutions / Q000009:adverse effects*; D012756:Sheep; D012976:Sodium Morrhuate / Q000009:adverse effects*
D005227:Fatty Acids; D012597:Sclerosing Solutions; D012976:Sodium Morrhuate